Viking Therapeutics Inc (VKTX) — Technical state
As of 2026-11-12 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 28 out of 100 (momentum 25 · quality 2), as of 2026-11-14.
- Signal: Stochastic turned down — Its stochastic crossed down from overbought (%K 70.2 under %D 77.8) today — momentum is cooling. (as of 2026-11-12)
- Trend: Viking Therapeutics Inc trades 6.3% below its 50-day and 14.3% below its 200-day moving average. (as of 2026-11-12)
- Index seat: HALO Growth 100
Viking Therapeutics is a clinical-stage biopharmaceutical company developing treatments for metabolic and endocrine disorders. Its lead programme is an oral thyroid hormone receptor beta agonist being tested against liver disease, alongside a selective androgen receptor modulator for post-fracture recovery and a dual GLP-1 agonist in early-stage trials.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the VKTX overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Its stochastic crossed down from overbought (%K 70.2 under %D 77.8) today — momentum is cooling.
The moving-average stack
- vs 20-day+4.2%
- vs 50-day-6.3%
- vs 200-day-14.3%
- 52-week band36.1% off the high · +15.8% off the low
- Streak3 consecutive down sessions
- Stochastic%K 70.2 · %D 77.8 · down cross
Continue: the VKTX chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-11-12
Quick answers
What is the current Closelooknet signal on VKTX?
Stochastic turned down — Its stochastic crossed down from overbought (%K 70.2 under %D 77.8) today — momentum is cooling. As of 2026-11-12; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is VKTX above its 50-day and 200-day moving averages?
As of 2026-11-12, Viking Therapeutics Inc trades -6.3% below its 50-day and -14.3% below its 200-day average, with the 20-day +4.2% away.
How far is VKTX from its 52-week high?
36.1% below the 52-week high and 15.8% above the 52-week low, as of 2026-11-12.
Related in the Closelooknet universe
same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- DECK Deckers Outdoor Corporation
- WISE.L Wise plc
- RACE Ferrari NV
- REGN Regeneron Pharmaceuticals Inc
- LLY Eli Lilly and Company
- DXCM DexCom Inc
- HDB HDFC Bank Limited ADR
- TOST Toast Inc
- GMED Globus Medical
- VRSK Verisk Analytics Inc
- DB1.DE Deutsche Börse AG
- ELF ELF Beauty Inc
- HALO Halozyme Therapeutics Incindustry
- ONC BeOne Medicines AGindustry
- ARGX.BR Argen-Xindustry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- CORT Corcept Therapeutics Incorporatedindustry
- REPL Replimune Group Incindustry
- KOD Kodiak Sciences Incindustry